Occurrence of human papillomavirus and p53 gene mutations in Kaposi's sarcoma.
Epidemiological evidence indicates that a sexually transmitted agent might be involved in the etiopathogenesis of Kaposi's sarcoma (KS). The prevalence of human papillomaviruses (HPV) in KS has been the focus of several investigations that have reported conflicting data. In addition, mutations of the p53 gene, which are the most frequent genetic changes found in human tumors, are absent in HPV-positive cervical carcinomas leading to the hypothesis that the function of p53 in HPV-positive tumors is inactivated through binding to the E6 viral gene product. Thus, the present study was designed to investigate the presence of HPV and p53 gene mutations in 17 formalin-fixed, paraffin-embedded KS [7 acquired immunodeficiency syndrome-KS (AIDS-KS) and 10 classic KS] specimens. HPV 6 DNA was detected in an AIDS-KS specimen, and HPV 16 DNA was found in 3 classic KS specimens. Heterozygous mutations of the p53 gene were detected in five (24%) KS samples. No p53 mutations were detected in HPV-positive KS. The p53 mutations were mainly transversions (four of five). These data indicate that HPV may contribute to the pathogenesis of some cases of KS and that p53 alteration may represent a key event in the progression of the malignancy.
Department of Virology and Immunology, Southwest Foundation for Biomedical Research, San Antonio, Texas 78228-0147.
F
F
Scinicariello
M J
MJ
Dolan
I
I
Nedelcu
S K
SK
Tyring
J K
JK
Hilliard
D004279:DNA, Viral / Q000032:analysis; D016158:Genes, p53 / Q000235:genetics*; D015658:HIV Infections / Q000150:complications; D015497:HIV-1; D006801:Humans; D027383:Papillomaviridae / Q000302:isolation & purification*; D017354:Point Mutation; D016133:Polymerase Chain Reaction; D012514:Sarcoma, Kaposi / Q000235:genetics* / Q000821:virology*
D004279:DNA, Viral